Study S000559

FLAT-SUGAR: FLuctuATion Reduction With inSULin and Glp-1 Added togetheR

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT01524705
Acronym: FLAT-SUGAR
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: DOUBLE
Status: COMPLETED
Enrollment: 102
Start: 2012-08
Primary completion: 2014-07
Lead sponsor: University of Washington
Conditions: Type 2 Diabetes
Interventions: DRUG:Insulin Glargine; DRUG:Metformin; DRUG:Prandial insulin; DRUG:Exenatide
Results posted: TRUE
Individual participant data sharing: YES

Registered primary outcomes

Coefficient of Variation at 26 Weeks Minus Coefficient of Variation at Baseline [At baseline, 6 months of intervention]

Linked records (2)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0025853	Glucose Variability in a 26-Week Randomized Comparison of Mealtime Treatment With Rapid-Acting Insulin Versus GLP-1 Agonist in Participants With Type 2 Diabetes at High Cardiovascular Risk. FLAT-SUGAR Trial Investigators, Diabetes care	2016	Randomized trial	PMID 27208320 DOI	registry reference RESULT:27208320
R0025468	Design of FLAT-SUGAR: Randomized Trial of Prandial Insulin Versus Prandial GLP-1 Receptor Agonist Together With Basal Insulin and Metformin for High-Risk Type 2 Diabetes. FLAT-SUGAR Trial Investigators, Diabetes care	2015	Randomized trial	PMID 26068865 DOI	cites ClinicalTrials.gov:NCT01524705; registry reference DERIVED:26068865